Bolton Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.5M Sell
39,763
-166
-0.4% -$43.8K 0.4% 50
2026
Q2
$10.1M Buy
39,929
+4,233
+12% +$987K 0.38% 53
2026
Q1
$8.73M Sell
35,696
-921
-3% -$215K 0.41% 51
2025
Q4
$7.58M Buy
36,617
+1,820
+5% +$360K 0.35% 58
2025
Q3
$6.45M Sell
34,797
-914
-3% -$157K 0.31% 72
2025
Q2
$5.45M Sell
35,711
-323
-0.9% -$49.6K 0.28% 84
2025
Q1
$5.98M Buy
+36,034
New +$5.64M 0.35% 66

Other funds holding JNJ

Bolton Securities's JNJ Position: Q3 2026 in Review

Bolton Securities reduced its Johnson & Johnson (JNJ) stake by 0.42% in Q3 2026, selling an estimated $43.8K and leaving 39,763 shares worth $10.5M. The position accounts for 0.4% of the portfolio, ranked #50.

Bolton Securities first reported a position in JNJ in Q1 2025 and has held it in 7 quarters since. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Bolton Securities held 39,763 shares of Johnson & Johnson worth $10.5M as of Q3 2026.
  • Bolton Securities sold 166 Johnson & Johnson shares in Q3 2026, an estimated $43.8K.
  • Johnson & Johnson made up 0.4% of Bolton Securities's portfolio in Q3 2026, its #50 holding.
  • Bolton Securities first reported a position in Johnson & Johnson in Q1 2025 and has held it in 7 quarters since.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.